Comparison
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 vs 3 4 Toe Cutaneous Syndactyly C5937396
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Exogenous Maternal Derived Androgen and 3 4 Toe Cutaneous Syndactyly for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
A condition caused when a pregnant person takes hormone medications containing androgens, affecting fetal development. The fetus has XX chromosomes. Stopping the offending agent is key, with specialist care for affected infants.
3 4 Toe Cutaneous Syndactyly C5937396
Skin webbing between the third and fourth toes, typically present at birth. Usually harmless and often left untreated unless it causes problems.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
Variable
3 4 Toe Cutaneous Syndactyly C5937396
0-0
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
severe
3 4 Toe Cutaneous Syndactyly C5937396
mild
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
Chronic
3 4 Toe Cutaneous Syndactyly C5937396
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
No
3 4 Toe Cutaneous Syndactyly C5937396
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
reproductive
3 4 Toe Cutaneous Syndactyly C5937396
musculoskeletal
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
endocrine
3 4 Toe Cutaneous Syndactyly C5937396
other
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-exogenous-maternal-derived-androgen-C5679874 and 3-4-toe-cutaneous-syndactyly-C5937396 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 | 3 4 Toe Cutaneous Syndactyly C5937396 | Discriminating power |
|---|---|---|---|
| Genital appearance | Possible atypical genital development in an XX fetus after androgen exposure. | No expected genital abnormality from isolated toe webbing. | High |
| Toe appearance | Toe webbing is not an established feature from the supplied data. | Skin connection between the third and fourth toes, typically from birth. | High |
| Exposure history | History of androgen-containing medication during pregnancy is central. | No medication exposure is required; it is usually congenital. | High |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 when
XX infant with atypical genital findings and documented maternal androgen exposure
The exposure history and chromosomal pattern match the supplied concept.
High
Pregnancy involving androgen-containing hormone medication
Stopping the suspected agent and specialist assessment are described as key.
Moderate
Need to distinguish an exposure-related developmental condition from a local limb finding
The reproductive and endocrine context favors the left concept.
High
Choose 3 4 Toe Cutaneous Syndactyly C5937396 when
Newborn with skin webbing limited to the third and fourth toes
This directly matches the described congenital finding.
High
No functional problem or family preference for observation
The source states it is usually harmless and often untreated.
Moderate
Local musculoskeletal concern without genital or endocrine features
The body-system and category differ from the left condition.
High
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 | 3 4 Toe Cutaneous Syndactyly C5937396 | Interpretation |
|---|---|---|---|
| Karyotype | XX chromosomal pattern is part of the concept. | No characteristic karyotype is established. | Karyotype supports classification only with clinical and exposure context. |
| Medication and pregnancy history | Androgen-containing medication exposure is relevant. | No specific exposure is expected. | History is essential; it does not by itself prove causation. |
| Foot examination or imaging | No specific toe abnormality is established. | Examination shows cutaneous, not necessarily bony, toe connection. | Imaging may be used if function or bone involvement is uncertain. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
- Outcome
- Course may be chronic and severity is described as severe, but individual outcome is not established.
- Factors
- Exposure timing, anatomy, and specialist care may matter; exact effects are unspecified.
3 4 Toe Cutaneous Syndactyly C5937396
- Outcome
- Usually mild and often stable without treatment.
- Factors
- Functional problems or family preference may influence management.
Time frame: Left onset is variable; right is typically present at birth. Both may be chronic.
Prognosis requires individualized clinician interpretation; no mortality or prevalence is supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental effects | May affect fetal sex development and require specialist follow-up. Usually limited to the toes and often harmless. Exact complications and frequency are not established here. |
| Functional limitation | Potential effects depend on individual anatomy and are not specified. Problems are uncommon but may prompt treatment if present. Function should be assessed rather than assumed. |
| Treatment-related issues | Stopping the offending exposure is described as key. Intervention is often unnecessary unless problems occur. No doses, procedures, or outcomes should be inferred. |
Patient education highlights
- HighDifferent conditions
Genital developmental effects and toe webbing involve different body systems and should not be conflated.
- HighMedication exposure
Report pregnancy medication use to a clinician; do not stop prescribed treatment without advice.
- MediumObservation
Isolated 3–4 toe skin webbing is often harmless, but new pain or functional difficulty needs review.